within Pharmacolibrary.Drugs.ATC.M;

model M03BC01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 1.4166666666666666e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0021666666666666666,
    Tlag           = 600,            
    Vdp             = 0.006,
    k12             = 1.7,
    k21             = 1.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03BC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Orphenadrine citrate is an anticholinergic drug that acts as a muscle relaxant. It is commonly used to relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Orphenadrine is also sometimes used in the management of Parkinsonian symptoms. It is available by prescription and remains approved for clinical use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Zhu, LL, et al., &amp; Zhou, Q (2024). Tizanidine: Advances in Pharmacology &amp; Therapeutics and Drug Formulations. <i>Journal of pain research</i> 17 1257–1271. DOI:<a href=&quot;https://doi.org/10.2147/JPR.S461032&quot;>10.2147/JPR.S461032</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38529017/&quot;>https://pubmed.ncbi.nlm.nih.gov/38529017</a></p></li><li><p>Labout, JJ, et al., &amp; Hespe, W (1982). Difference between single and multiple dose pharmacokinetics of orphenadrine hydrochloride in man. <i>European journal of clinical pharmacology</i> 21(4) 343–350. DOI:<a href=&quot;https://doi.org/10.1007/BF00637624&quot;>10.1007/BF00637624</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7056281/&quot;>https://pubmed.ncbi.nlm.nih.gov/7056281</a></p></li><li><p>Rutigliano, G, &amp; Labout, JJ (1982). The bioavailability of orphenadrine hydrochloride after intramuscular and oral administration. <i>The Journal of international medical research</i> 10(6) 447–450. DOI:<a href=&quot;https://doi.org/10.1177/030006058201000612&quot;>10.1177/030006058201000612</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7152086/&quot;>https://pubmed.ncbi.nlm.nih.gov/7152086</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03BC01;
